Survey says most women skip their recommended mammogram

Women cite a lack of time as the primary reason for not scheduling a mammogram, MedStar Health reported Oct. 2.

The organization's new consumer survey shows that, despite annual breast cancer awareness campaigns, celebrity sponsorships, and sports teams dressing in pink, most women are not getting their annual recommended mammogram. About 59% of women admit to forgoing the recommended annual mammogram, while another 23% say they’ve never had one at all. The survey was conducted by MedStar Health, a large not-for-profit health system in Maryland. 

These findings come at a time when breast cancer diagnoses continue to rise, with an annual increase of about 0.5%, according to the American Cancer Society. Notably, there has been a nearly 3% uptick in diagnoses among younger women under 40. This shift in statistics led the United States Preventative Task Force (USPSTF) to lower its recommended age for mammograms from 50 to 40 in May.

“Everyone’s breast cancer risk is different. Educating yourself about your own risk is key to catching it early,” physician assistant Stephanie Johnson, director of the MedStar Health's High-Risk Breast Cancer Program, said in a statement. “The American College of Radiology recommends that every woman calculate her risk with the Tyrer-Cuzick risk model at age 30 and about every five years after. This model considers at least eight factors for risk."

The survey delved into the reasons behind women's reluctance to undergo mammograms. The top reasons cited by women included not finding the time (34%), having a normal mammogram in the past (21%), and lacking a family history of breast cancer (17%).

Additionally, the survey uncovered some disparities in awareness, with 62% of respondents saying they did not know that age is a risk factor. When it comes to lifestyle risks, 56% of those surveyed said they did now know cigarette smoking increased the risk of getting breast cancer. 

The statement from MedStar did not reveal detailed demographic information on respondents, including how many there were.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.